These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 37835383)

  • 21. Estrogen receptor α regulates the expression of syndecan-1 in human breast carcinoma cells.
    Fleurot E; Goudin C; Hanoux V; Bonnamy PJ; Levallet J
    Endocr Relat Cancer; 2019 Jun; 26(6):615-628. PubMed ID: 30978702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
    Jordan VC; Brodie AM
    Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of estrogen receptor coregulators in endocrine resistant breast cancer.
    Altwegg KA; Vadlamudi RK
    Explor Target Antitumor Ther; 2021; 2(4):385-400. PubMed ID: 34528025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?
    Corti C; De Angelis C; Bianchini G; Malorni L; Giuliano M; Hamilton E; Jeselsohn R; Jhaveri K; Curigliano G; Criscitiello C
    Cancer Treat Rev; 2023 Jun; 117():102569. PubMed ID: 37146385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers.
    Raj GV; Sareddy GR; Ma S; Lee TK; Viswanadhapalli S; Li R; Liu X; Murakami S; Chen CC; Lee WR; Mann M; Krishnan SR; Manandhar B; Gonugunta VK; Strand D; Tekmal RR; Ahn JM; Vadlamudi RK
    Elife; 2017 Aug; 6():. PubMed ID: 28786813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role.
    Lloyd MR; Wander SA; Hamilton E; Razavi P; Bardia A
    Ther Adv Med Oncol; 2022; 14():17588359221113694. PubMed ID: 35923930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine resistance: what do we know?
    Miller TW
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives.
    Sukocheva OA; Lukina E; Friedemann M; Menschikowski M; Hagelgans A; Aliev G
    Semin Cancer Biol; 2022 Jul; 82():35-59. PubMed ID: 33301860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-aromatase and anti-estrogenic activity of plant products in the treatment of estrogen receptor-positive breast cancer.
    Verhoog NJD; Spies LL
    J Steroid Biochem Mol Biol; 2024 Oct; 243():106581. PubMed ID: 38997071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies.
    Ozyurt R; Ozpolat B
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors.
    Suba Z
    Recent Pat Anticancer Drug Discov; 2018; 13(4):428-444. PubMed ID: 30027855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activating Mutations of ESR1, BRCA1 and CYP19 Aromatase Genes Confer Tumor Response in Breast Cancers Treated with Antiestrogens.
    Suba Z
    Recent Pat Anticancer Drug Discov; 2017; 12(2):136-147. PubMed ID: 28245776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine Resistance in Hormone Receptor Positive Breast Cancer-From Mechanism to Therapy.
    Rani A; Stebbing J; Giamas G; Murphy J
    Front Endocrinol (Lausanne); 2019; 10():245. PubMed ID: 31178825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic targeting in the estrogen receptor hormonal pathway.
    Katzenellenbogen BS; Frasor J
    Semin Oncol; 2004 Feb; 31(1 Suppl 3):28-38. PubMed ID: 15052541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.
    Ribas R; Ghazoui Z; Gao Q; Pancholi S; Rani A; Dunbier A; Dowsett M; Martin LA
    Breast Cancer Res; 2014 Oct; 16(5):447. PubMed ID: 25358600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
    Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.
    Chan HJ; Petrossian K; Chen S
    J Steroid Biochem Mol Biol; 2016 Jul; 161():73-83. PubMed ID: 26277097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
    Uray IP; Brown PH
    Recent Results Cancer Res; 2011; 188():147-62. PubMed ID: 21253797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer.
    Zhao M; Ramaswamy B
    World J Clin Oncol; 2014 Aug; 5(3):248-62. PubMed ID: 25114842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.